NASDAQ:RNAC

Examining the Potential Price Growth of Cartesian Therapeutics Inc (RNAC)
Daniel Torres
Cartesian Therapeutics Inc’s recently made public that its Director BARABE TIMOTHY C acquired Company’s shares for reported $0.21 million on ...

Cartesian Therapeutics Inc’s recently made public that its Director BARABE TIMOTHY C acquired Company’s shares for reported $0.21 million on ...